Analysts: Glenmark Pharmaceuticals Ltd (GLEN.NS)

GLEN.NS on National Stock Exchange of India

714.85INR
23 Oct 2014
Price Change (% chg)

Rs10.65 (+1.51%)
Prev Close
Rs704.20
Open
Rs709.90
Day's High
Rs716.75
Day's Low
Rs707.00
Volume
52,671
Avg. Vol
744,210
52-wk High
Rs790.00
52-wk Low
Rs487.60

Search Stocks

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -- March 25 Oct 2014

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 10 12 12 12
(2) OUTPERFORM 14 15 16 17
(3) HOLD 8 7 8 7
(4) UNDERPERFORM 2 2 2 1
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 2.06 1.97 2.00 1.92

Consensus Estimates Analysis

Sales and Profit Figures in India Rupee (INR)
Earnings and Dividend Figures in India Rupee (INR)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Dec-14 2 18,339.30 19,207.00 17,471.50 --
Quarter Ending Mar-15 2 20,301.00 20,317.00 20,285.10 --
Year Ending Mar-14 32 59,320.60 62,351.00 58,151.00 --
Year Ending Mar-15 31 69,774.10 72,505.50 67,302.00 70,293.90
Year Ending Mar-16 31 81,625.80 89,034.90 76,011.70 81,436.30
Earnings (per share)
Year Ending Mar-14 34 25.62 29.30 23.00 --
Year Ending Mar-15 32 31.85 36.40 29.50 34.05
Year Ending Mar-16 32 39.63 48.30 35.36 40.34
LT Growth Rate (%) 3 24.30 36.80 14.50 22.58

Historical Surprises

Sales and Profit Figures in India Rupee (INR)
Earnings and Dividend Figures in India Rupee (INR)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Jun-14 14,922.80 14,778.20 144.63 0.97
Quarter Ending Mar-14 16,053.10 16,817.40 764.28 4.76
Quarter Ending Dec-13 15,616.80 16,012.20 395.42 2.53
Quarter Ending Sep-13 14,695.20 14,630.10 65.10 0.44
Quarter Ending Jun-13 12,578.70 12,378.80 199.83 1.59
Earnings (per share)
Quarter Ending Jun-14 6.20 6.81 0.61 9.75
Quarter Ending Mar-14 7.15 9.62 2.47 34.54
Quarter Ending Dec-13 6.90 7.97 1.07 15.46
Quarter Ending Sep-13 6.38 5.69 0.69 10.87
Quarter Ending Jun-13 5.66 4.75 0.91 16.03

Consensus Estimates Trend

Sales and Profit Figures in India Rupee (INR)
Earnings and Dividend Figures in India Rupee (INR)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Dec-14 18,339.30 18,339.30 18,052.30 18,052.30 --
Quarter Ending Mar-15 20,301.00 20,301.00 19,965.00 19,965.00 --
Year Ending Mar-14 59,320.60 -- -- -- --
Year Ending Mar-15 69,774.10 69,760.50 69,746.50 69,757.20 70,293.90
Year Ending Mar-16 81,625.80 81,567.00 81,481.90 81,454.20 81,436.30
Earnings (per share)
Year Ending Mar-14 25.62 -- -- -- --
Year Ending Mar-15 31.85 31.73 31.66 31.65 34.05
Year Ending Mar-16 39.63 39.44 39.26 39.19 40.34

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Dec-14 0 0 1 0
Quarter Ending Mar-15 0 0 1 0
Year Ending Mar-14 -- -- -- --
Year Ending Mar-15 0 0 2 3
Year Ending Mar-16 0 0 3 2
Earnings
Year Ending Mar-14 -- -- -- --
Year Ending Mar-15 0 0 4 1
Year Ending Mar-16 0 0 4 1

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Reuters Investment Profile
$20.00
Provider: Wright Reports
$75.00
Provider: Spark Capital Advisors(India) Private Limited
$46.00
Provider: Axis Capital Limited
$92.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks